QUICKLINKS AND VIEW OPITONS
Acomplia’s (rimonabant) increases need for anti-anxiety drugs and sleeping pills
Thursday, June 14, 2007 1:37 am Email this article
Acomplia (rimonabant) increased the need for anti-anxiety drugs and sleeping pills according to the U.S. Food and Drug Administration (FDA) briefing document about the drug. These drugs were prescribed for 8.5 percent of patients taking 20 mg of Acomplia versus 4.1 percent of patients on placebo.
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2017 - Larry Hobbs - All Rights Reserved.